Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
08HH:FRA
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
2,05 €
-2,52%
(-0,053) 1D
30 აპრ, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 08HH...
Open
2,05 €
High
2,05 €
Low
2,05 €
Mkt. cap
70,24 მლრდ.
Avg. vol.
471,00
Volume
0,00
52-wk high
3,22 €
52-wk low
1,51 €
No. of employees
41 ათ.
News stories
From sources across the web
Profile
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International. As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
About Shanghai Fosun Pharmaceutical (Group) Ord Shs H
CEOლიუ აი | ვენ დეიონგ
Employees40,6 ათ.
Founded1994
Headquarters-
SectorPharmaceutical industry
Websitefosunpharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
10,09 მლრდ.
9,88 მლრდ.
12,27 მლრდ.
10,07 მლრდ.
Cost of goods sold
5,22 მლრდ.
5,08 მლრდ.
5,65 მლრდ.
5,07 მლრდ.
Cost of revenue
5,22 მლრდ.
5,08 მლრდ.
5,65 მლრდ.
5,07 მლრდ.
Research and development expenses
979,21 მლნ.
1,01 მლრდ.
1,28 მლრდ.
896,79 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,14 მლრდ.
3,10 მლრდ.
4,44 მლრდ.
3,27 მლრდ.
Operating expense
4,19 მლრდ.
4,04 მლრდ.
5,92 მლრდ.
4,19 მლრდ.
Total operating expenses
9,41 მლრდ.
9,12 მლრდ.
11,57 მლრდ.
9,26 მლრდ.
Operating income
685,50 მლნ.
758,38 მლნ.
699,05 მლნ.
813,78 მლნ.
Other non operating income
-4,87 მლნ.
-116,85 მლნ.
107,33 მლნ.
2,03 მლნ.
EBT including unusual items
1,37 მლრდ.
1,12 მლრდ.
1,27 მლრდ.
1,36 მლრდ.
EBT excluding unusual items
1,16 მლრდ.
1,49 მლრდ.
1,10 მლრდ.
1,21 მლრდ.
Income tax expense
212,30 მლნ.
162,98 მლნ.
82,80 მლნ.
277,92 მლნ.
Effective tax rate
15,49%
14,57%
6,50%
20,47%
Other operating expenses
49,69 მლნ.
-92,19 მლნ.
117,57 მლნ.
19,04 მლნ.
Net income
937,21 მლნ.
821,33 მლნ.
847,27 მლნ.
870,83 მლნ.
Net profit margin
9,28%
8,31%
6,91%
8,64%
Earnings per share
-
-
-
-
Interest and investment income
925,83 მლნ.
1,05 მლრდ.
732,13 მლნ.
689,67 მლნ.
Interest expense
-323,25 მლნ.
-321,25 მლნ.
-291,32 მლნ.
-296,51 მლნ.
Net interest expenses
602,58 მლნ.
727,28 მლნ.
440,80 მლნ.
393,16 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,38 მლრდ.
1,39 მლრდ.
1,47 მლრდ.
1,59 მლრდ.
Gain or loss from assets sale
-2,12 მლნ.
2,12 მლნ.
-69,35 მლნ.
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer